NCT03482050View on ClinicalTrials.gov

A Study to Evaluate Transplantation of Astrocytes Derived From Human Embryonic Stem Cells, in Patients With Amyotrophic Lateral Sclerosis (ALS)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 12, 2018

Primary Completion Date

June 22, 2020

Study Completion Date

June 22, 2020

Conditions
ALS (Amyotrophic Lateral Sclerosis)
Interventions
BIOLOGICAL

AstroRx

Astrocytes derived from human embryonic stem cells

Trial Locations (1)

Unknown

Hadassah Ein Kerem Medical Center, Jerusalem

Sponsors

Lead Sponsor

Kadimastem
All Listed Sponsors
lead

Kadimastem

INDUSTRY